- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Precision Cancer Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Precision Cancer Tests market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer Research Centers accounting for % of the Precision Cancer Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Imaging segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, and Foundation Medicine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Precision Cancer Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Imaging
In Vitro Diagnostic
Others
Market segment by Application, can be divided into
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Market segment by players, this report covers
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Precision Cancer Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Precision Cancer Tests, with revenue, gross margin and global market share of Precision Cancer Tests from 2019 to 2022.
Chapter 3, the Precision Cancer Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Precision Cancer Tests market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Precision Cancer Tests research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Precision Cancer Tests
1.2 Classification of Precision Cancer Tests by Type
1.2.1 Overview: Global Precision Cancer Tests Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Precision Cancer Tests Revenue Market Share by Type in 2021
1.2.3 Imaging
1.2.4 In Vitro Diagnostic
1.2.5 Others
1.3 Global Precision Cancer Tests Market by Application
1.3.1 Overview: Global Precision Cancer Tests Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.3.6 Others
1.4 Global Precision Cancer Tests Market Size & Forecast
1.5 Global Precision Cancer Tests Market Size and Forecast by Region
1.5.1 Global Precision Cancer Tests Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Precision Cancer Tests Market Size by Region, (2017-2022)
1.5.3 North America Precision Cancer Tests Market Size and Prospect (2017-2028)
1.5.4 Europe Precision Cancer Tests Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Precision Cancer Tests Market Size and Prospect (2017-2028)
1.5.6 South America Precision Cancer Tests Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Precision Cancer Tests Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Precision Cancer Tests Market Drivers
1.6.2 Precision Cancer Tests Market Restraints
1.6.3 Precision Cancer Tests Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Precision Cancer Tests Product and Solutions
2.1.4 Abbott Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Recent Developments and Future Plans
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Precision Cancer Tests Product and Solutions
2.2.4 BD Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BD Recent Developments and Future Plans
2.3 Bio-Rad
2.3.1 Bio-Rad Details
2.3.2 Bio-Rad Major Business
2.3.3 Bio-Rad Precision Cancer Tests Product and Solutions
2.3.4 Bio-Rad Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bio-Rad Recent Developments and Future Plans
2.4 Cynvenio Biosystems
2.4.1 Cynvenio Biosystems Details
2.4.2 Cynvenio Biosystems Major Business
2.4.3 Cynvenio Biosystems Precision Cancer Tests Product and Solutions
2.4.4 Cynvenio Biosystems Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Cynvenio Biosystems Recent Developments and Future Plans
2.5 Foundation Medicine
2.5.1 Foundation Medicine Details
2.5.2 Foundation Medicine Major Business
2.5.3 Foundation Medicine Precision Cancer Tests Product and Solutions
2.5.4 Foundation Medicine Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Foundation Medicine Recent Developments and Future Plans
2.6 Genomic Health
2.6.1 Genomic Health Details
2.6.2 Genomic Health Major Business
2.6.3 Genomic Health Precision Cancer Tests Product and Solutions
2.6.4 Genomic Health Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Genomic Health Recent Developments and Future Plans
2.7 Illumina
2.7.1 Illumina Details
2.7.2 Illumina Major Business
2.7.3 Illumina Precision Cancer Tests Product and Solutions
2.7.4 Illumina Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Illumina Recent Developments and Future Plans
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business
2.8.3 Myriad Genetics Precision Cancer Tests Product and Solutions
2.8.4 Myriad Genetics Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Myriad Genetics Recent Developments and Future Plans
2.9 NanoString Technologies
2.9.1 NanoString Technologies Details
2.9.2 NanoString Technologies Major Business
2.9.3 NanoString Technologies Precision Cancer Tests Product and Solutions
2.9.4 NanoString Technologies Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 NanoString Technologies Recent Developments and Future Plans
2.10 QIAGEN
2.10.1 QIAGEN Details
2.10.2 QIAGEN Major Business
2.10.3 QIAGEN Precision Cancer Tests Product and Solutions
2.10.4 QIAGEN Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 QIAGEN Recent Developments and Future Plans
2.11 Randox Laboratories
2.11.1 Randox Laboratories Details
2.11.2 Randox Laboratories Major Business
2.11.3 Randox Laboratories Precision Cancer Tests Product and Solutions
2.11.4 Randox Laboratories Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Randox Laboratories Recent Developments and Future Plans
2.12 Roche
2.12.1 Roche Details
2.12.2 Roche Major Business
2.12.3 Roche Precision Cancer Tests Product and Solutions
2.12.4 Roche Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Roche Recent Developments and Future Plans
2.13 Philips
2.13.1 Philips Details
2.13.2 Philips Major Business
2.13.3 Philips Precision Cancer Tests Product and Solutions
2.13.4 Philips Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Philips Recent Developments and Future Plans
2.14 Thermo Fisher Scientific
2.14.1 Thermo Fisher Scientific Details
2.14.2 Thermo Fisher Scientific Major Business
2.14.3 Thermo Fisher Scientific Precision Cancer Tests Product and Solutions
2.14.4 Thermo Fisher Scientific Precision Cancer Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Precision Cancer Tests Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Precision Cancer Tests Players Market Share in 2021
3.2.2 Top 10 Precision Cancer Tests Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Precision Cancer Tests Players Head Office, Products and Services Provided
3.4 Precision Cancer Tests Mergers & Acquisitions
3.5 Precision Cancer Tests New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Precision Cancer Tests Revenue and Market Share by Type (2017-2022)
4.2 Global Precision Cancer Tests Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Precision Cancer Tests Revenue Market Share by Application (2017-2022)
5.2 Global Precision Cancer Tests Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Precision Cancer Tests Revenue by Type (2017-2028)
6.2 North America Precision Cancer Tests Revenue by Application (2017-2028)
6.3 North America Precision Cancer Tests Market Size by Country
6.3.1 North America Precision Cancer Tests Revenue by Country (2017-2028)
6.3.2 United States Precision Cancer Tests Market Size and Forecast (2017-2028)
6.3.3 Canada Precision Cancer Tests Market Size and Forecast (2017-2028)
6.3.4 Mexico Precision Cancer Tests Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Precision Cancer Tests Revenue by Type (2017-2028)
7.2 Europe Precision Cancer Tests Revenue by Application (2017-2028)
7.3 Europe Precision Cancer Tests Market Size by Country
7.3.1 Europe Precision Cancer Tests Revenue by Country (2017-2028)
7.3.2 Germany Precision Cancer Tests Market Size and Forecast (2017-2028)
7.3.3 France Precision Cancer Tests Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Precision Cancer Tests Market Size and Forecast (2017-2028)
7.3.5 Russia Precision Cancer Tests Market Size and Forecast (2017-2028)
7.3.6 Italy Precision Cancer Tests Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Precision Cancer Tests Revenue by Type (2017-2028)
8.2 Asia-Pacific Precision Cancer Tests Revenue by Application (2017-2028)
8.3 Asia-Pacific Precision Cancer Tests Market Size by Region
8.3.1 Asia-Pacific Precision Cancer Tests Revenue by Region (2017-2028)
8.3.2 China Precision Cancer Tests Market Size and Forecast (2017-2028)
8.3.3 Japan Precision Cancer Tests Market Size and Forecast (2017-2028)
8.3.4 South Korea Precision Cancer Tests Market Size and Forecast (2017-2028)
8.3.5 India Precision Cancer Tests Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Precision Cancer Tests Market Size and Forecast (2017-2028)
8.3.7 Australia Precision Cancer Tests Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Precision Cancer Tests Revenue by Type (2017-2028)
9.2 South America Precision Cancer Tests Revenue by Application (2017-2028)
9.3 South America Precision Cancer Tests Market Size by Country
9.3.1 South America Precision Cancer Tests Revenue by Country (2017-2028)
9.3.2 Brazil Precision Cancer Tests Market Size and Forecast (2017-2028)
9.3.3 Argentina Precision Cancer Tests Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Precision Cancer Tests Revenue by Type (2017-2028)
10.2 Middle East & Africa Precision Cancer Tests Revenue by Application (2017-2028)
10.3 Middle East & Africa Precision Cancer Tests Market Size by Country
10.3.1 Middle East & Africa Precision Cancer Tests Revenue by Country (2017-2028)
10.3.2 Turkey Precision Cancer Tests Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Precision Cancer Tests Market Size and Forecast (2017-2028)
10.3.4 UAE Precision Cancer Tests Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Precision Cancer Tests Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Precision Cancer Tests Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Precision Cancer Tests Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Precision Cancer Tests Revenue (USD Million) by Region (2017-2022)
Table 5. Global Precision Cancer Tests Revenue Market Share by Region (2023-2028)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Precision Cancer Tests Product and Solutions
Table 9. Abbott Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BD Corporate Information, Head Office, and Major Competitors
Table 11. BD Major Business
Table 12. BD Precision Cancer Tests Product and Solutions
Table 13. BD Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Major Business
Table 16. Bio-Rad Precision Cancer Tests Product and Solutions
Table 17. Bio-Rad Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Cynvenio Biosystems Corporate Information, Head Office, and Major Competitors
Table 19. Cynvenio Biosystems Major Business
Table 20. Cynvenio Biosystems Precision Cancer Tests Product and Solutions
Table 21. Cynvenio Biosystems Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Foundation Medicine Corporate Information, Head Office, and Major Competitors
Table 23. Foundation Medicine Major Business
Table 24. Foundation Medicine Precision Cancer Tests Product and Solutions
Table 25. Foundation Medicine Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 27. Genomic Health Major Business
Table 28. Genomic Health Precision Cancer Tests Product and Solutions
Table 29. Genomic Health Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Illumina Corporate Information, Head Office, and Major Competitors
Table 31. Illumina Major Business
Table 32. Illumina Precision Cancer Tests Product and Solutions
Table 33. Illumina Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 35. Myriad Genetics Major Business
Table 36. Myriad Genetics Precision Cancer Tests Product and Solutions
Table 37. Myriad Genetics Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. NanoString Technologies Corporate Information, Head Office, and Major Competitors
Table 39. NanoString Technologies Major Business
Table 40. NanoString Technologies Precision Cancer Tests Product and Solutions
Table 41. NanoString Technologies Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 43. QIAGEN Major Business
Table 44. QIAGEN Precision Cancer Tests Product and Solutions
Table 45. QIAGEN Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Randox Laboratories Corporate Information, Head Office, and Major Competitors
Table 47. Randox Laboratories Major Business
Table 48. Randox Laboratories Precision Cancer Tests Product and Solutions
Table 49. Randox Laboratories Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Roche Corporate Information, Head Office, and Major Competitors
Table 51. Roche Major Business
Table 52. Roche Precision Cancer Tests Product and Solutions
Table 53. Roche Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Philips Corporate Information, Head Office, and Major Competitors
Table 55. Philips Major Business
Table 56. Philips Precision Cancer Tests Product and Solutions
Table 57. Philips Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 59. Thermo Fisher Scientific Major Business
Table 60. Thermo Fisher Scientific Precision Cancer Tests Product and Solutions
Table 61. Thermo Fisher Scientific Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Precision Cancer Tests Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Precision Cancer Tests Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Precision Cancer Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Precision Cancer Tests Players Head Office, Products and Services Provided
Table 66. Precision Cancer Tests Mergers & Acquisitions in the Past Five Years
Table 67. Precision Cancer Tests New Entrants and Expansion Plans
Table 68. Global Precision Cancer Tests Revenue (USD Million) by Type (2017-2022)
Table 69. Global Precision Cancer Tests Revenue Share by Type (2017-2022)
Table 70. Global Precision Cancer Tests Revenue Forecast by Type (2023-2028)
Table 71. Global Precision Cancer Tests Revenue by Application (2017-2022)
Table 72. Global Precision Cancer Tests Revenue Forecast by Application (2023-2028)
Table 73. North America Precision Cancer Tests Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Precision Cancer Tests Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Precision Cancer Tests Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Precision Cancer Tests Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Precision Cancer Tests Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Precision Cancer Tests Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Precision Cancer Tests Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Precision Cancer Tests Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Precision Cancer Tests Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Precision Cancer Tests Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Precision Cancer Tests Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Precision Cancer Tests Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Precision Cancer Tests Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Precision Cancer Tests Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Precision Cancer Tests Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Precision Cancer Tests Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Precision Cancer Tests Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Precision Cancer Tests Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Precision Cancer Tests Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Precision Cancer Tests Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Precision Cancer Tests Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Precision Cancer Tests Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Precision Cancer Tests Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Precision Cancer Tests Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Precision Cancer Tests Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Precision Cancer Tests Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Precision Cancer Tests Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Precision Cancer Tests Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Precision Cancer Tests Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Precision Cancer Tests Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Precision Cancer Tests Picture
Figure 2. Global Precision Cancer Tests Revenue Market Share by Type in 2021
Figure 3. Imaging
Figure 4. In Vitro Diagnostic
Figure 5. Others
Figure 6. Precision Cancer Tests Revenue Market Share by Application in 2021
Figure 7. Cancer Research Centers Picture
Figure 8. Cancer Hospital Picture
Figure 9. Surgical Centers Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Precision Cancer Tests Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Precision Cancer Tests Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Precision Cancer Tests Revenue Market Share by Region (2017-2028)
Figure 15. Global Precision Cancer Tests Revenue Market Share by Region in 2021
Figure 16. North America Precision Cancer Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Precision Cancer Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Precision Cancer Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Precision Cancer Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Precision Cancer Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Precision Cancer Tests Market Drivers
Figure 22. Precision Cancer Tests Market Restraints
Figure 23. Precision Cancer Tests Market Trends
Figure 24. Abbott Recent Developments and Future Plans
Figure 25. BD Recent Developments and Future Plans
Figure 26. Bio-Rad Recent Developments and Future Plans
Figure 27. Cynvenio Biosystems Recent Developments and Future Plans
Figure 28. Foundation Medicine Recent Developments and Future Plans
Figure 29. Genomic Health Recent Developments and Future Plans
Figure 30. Illumina Recent Developments and Future Plans
Figure 31. Myriad Genetics Recent Developments and Future Plans
Figure 32. NanoString Technologies Recent Developments and Future Plans
Figure 33. QIAGEN Recent Developments and Future Plans
Figure 34. Randox Laboratories Recent Developments and Future Plans
Figure 35. Roche Recent Developments and Future Plans
Figure 36. Philips Recent Developments and Future Plans
Figure 37. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 38. Global Precision Cancer Tests Revenue Share by Players in 2021
Figure 39. Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Precision Cancer Tests Revenue Market Share in 2021
Figure 41. Global Top 10 Players Precision Cancer Tests Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Precision Cancer Tests Revenue Share by Type in 2021
Figure 44. Global Precision Cancer Tests Market Share Forecast by Type (2023-2028)
Figure 45. Global Precision Cancer Tests Revenue Share by Application in 2021
Figure 46. Global Precision Cancer Tests Market Share Forecast by Application (2023-2028)
Figure 47. North America Precision Cancer Tests Sales Market Share by Type (2017-2028)
Figure 48. North America Precision Cancer Tests Sales Market Share by Application (2017-2028)
Figure 49. North America Precision Cancer Tests Revenue Market Share by Country (2017-2028)
Figure 50. United States Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Precision Cancer Tests Sales Market Share by Type (2017-2028)
Figure 54. Europe Precision Cancer Tests Sales Market Share by Application (2017-2028)
Figure 55. Europe Precision Cancer Tests Revenue Market Share by Country (2017-2028)
Figure 56. Germany Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Precision Cancer Tests Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Precision Cancer Tests Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Precision Cancer Tests Revenue Market Share by Region (2017-2028)
Figure 64. China Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Precision Cancer Tests Sales Market Share by Type (2017-2028)
Figure 71. South America Precision Cancer Tests Sales Market Share by Application (2017-2028)
Figure 72. South America Precision Cancer Tests Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Precision Cancer Tests Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Precision Cancer Tests Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Precision Cancer Tests Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Precision Cancer Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
